J9021 Inj, aspara, rylaze, 0.1 mg

Injection, asparaginase, recombinant, (rylaze), 0.1 mg

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 1500 units per day (practitioner), rationale: Prescribing Information